Cellular Origins of EGFR‐Driven Lung Cancer Cells Determine Sensitivity to Therapy

Targeting the epidermal growth factor receptor (EGFR) with tyrosine kinase inhibitors (TKIs) is one of the major precision medicine treatment options for lung adenocarcinoma. Due to common development of drug resistance to first‐ and second‐generation TKIs, third‐generation inhibitors, including osi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Fan, Liu, Jinpeng, Flight, Robert M., Naughton, Kassandra J., Lukyanchuk, Alexsandr, Edgin, Abigail R., Song, Xiulong, Zhang, Haikuo, Wong, Kwok‐Kin, Moseley, Hunter N. B., Wang, Chi, Brainson, Christine F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596110/
https://www.ncbi.nlm.nih.gov/pubmed/34622577
http://dx.doi.org/10.1002/advs.202101999

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596110/
https://www.ncbi.nlm.nih.gov/pubmed/34622577
http://dx.doi.org/10.1002/advs.202101999

Ejemplares similares